Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Experts Discuss Proposed Giant Cell Arteritis Risk Tool

Kathy Holliman  |  Issue: April 2018  |  April 26, 2018

The a priori variables chosen for the prediction model included age, gender, jaw claudication, new-onset headache, clinical temporal artery abnormality, ischemic vision loss, diplopia, platelet level, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Only cases that had details on each of those variables were included in the analysis. According to Dr. Ing, one of the most difficult elements involved was finding patients with complete blood work results (i.e., ESR, CRP, platelets) who had had the temporal artery biopsy prior to 14 days of glucocorticoid therapy.

‘The prediction model provides a numeric final output probability of biopsy-proven GCA.’ —Dr. Ing

Statistically Significant Predictors

The data analysis found the statistically significant predictors of a positive temporal artery biopsy included age, jaw claudication, ischemic vision loss, higher platelet level and log CRP. The variables that were not statistically significant predictors included ESR, gender, new-onset headache and temporal artery abnormality.

Dr. Ing says the group found no surprises among the predictive variables. “It was interesting, however, to find that thrombocytosis, or elevated platelets, was such a strong predictor,” he says. “In our study, the log transform of the CRP divided by its upper limit of normal was a bigger predictor for GCA than the raw CRP.” In addition, he says, “[Because] ischemic vision loss (i.e., anterior ischemic optic neuropathy, posterior ischemic optic neuropathy, central retinal artery occlusion) was a statistically significant predictor for biopsy-proven GCA, this may explain why binocular diplopia was not.”

* Gender and diplopia were NOT predictive for GCA in this study.

(click for larger image) Figure 1: Multivariable Prediction Model for Suspected Giant Cell Arteritis: Development & Validation
* Gender and diplopia were NOT predictive for GCA in this study.

Source: Clinical Ophthalmology by Society for Clinical Ophthalmology (Great Britain). Reproduced with permission of Dove Medical Press Limited in The Rheumatologist via Copyright Clearance Center.

(click for larger image) Source: Clinical Ophthalmology by Society for Clinical Ophthalmology (Great Britain). Reproduced with permission of Dove Medical Press Limited in The Rheumatologist via Copyright Clearance Center.

“The prediction model provides a numeric final output probability of biopsy-proven GCA so patients and their clinicians can objectively decide whether to initiate glucocorticoid therapy and/or undergo a temporal artery biopsy,” Dr. Ing says. The final model assigns a probability of a positive temporal artery biopsy based on the following variables: age, gender, jaw claudication, diplopia, new-onset headache, temporal artery abnormality, funduscopic abnormality, thrombo­cytosis, ESR and CRP.

The output calculator should be interpreted in light of the cutpoint table. A nomogram for the 10-variable prediction model “allows clinicians without a formal training in statistics to graphically understand how the odds ratios and confidence intervals of each predictor contributes to the final probability for GCA on logistic regression,” he says.2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Vasculitis Tagged with:Giant Cell ArteritisVasculitis

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Giant Cell Arteritis Challenging to Diagnose, Manage

    March 1, 2015

    Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences